New Tool Reveals Risks and Origins of Generic Drugs
TL;DR Summary
ProPublica investigated the FDA's limited testing of generic drugs, revealing irregularities and quality concerns in widely used medications like bupropion and metoprolol, which could compromise their effectiveness and patient safety, highlighting the agency's reliance on manufacturers and sporadic testing practices.
- The FDA Often Doesn’t Test the Quality of Generic Drugs, So We Did ProPublica
- Rx inspector: ProPublica’s new tool provides drug info the FDA won’t Medical Marketing and Media
- US Senator Warns Foreign-Made Generics May Put Families At Risk Ommcom News
- Medicine Cabinet Roulette: Senate Panel Flags ‘Dangerous’ Dependence On Foreign Drugs AOL.com
- How We Created a Tool That Tells You Where Your Generic Drugs Were Made ProPublica
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
19 min
vs 20 min read
Condensed
99%
3,861 → 40 words
Want the full story? Read the original article
Read on ProPublica